Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Inscripta

Request full access

Developing the world’s first benchtop platform for scalable digital genome engineering

Pleasanton, United StatesFounded 2015Biotech & Life Sciences

About Inscripta

Inscripta, Inc., established in 2015, operates within the life science technology sector, focusing on advancing genome engineering to fuel the bioeconomy. The company was founded by a trio of individuals with deep expertise in the field: Andrew Garst, Ryan Gill, and Kevin Ness. Gill, a professor at the University of Colorado, Boulder, has a background in chemical and biological engineering, while Ness previously served as CEO of biotech firm QuantaLife, which was acquired by Bio-Rad. This collective experience in both academia and commercial life sciences laid the groundwork for Inscripta's mission.

The company's core business revolves around providing tools that empower scientists to engineer microbes for biomanufacturing, aiming to create sustainable alternatives to traditional manufacturing processes. Inscripta targets researchers and scientists in academic institutions, as well as commercial entities in sectors like industrial chemicals, healthcare, and agriculture. Its business model centers on the sale of its integrated platform, consumables, and software, which together streamline the complex process of genome editing.

Inscripta's primary offering is the Onyx® platform, a comprehensive solution for digital genome engineering. This platform automates the engineering of microbial genomes, allowing scientists to generate and test vast libraries of genetic edits simultaneously. The key components include proprietary gene-editing enzymes (MADzymes), engineered cells, intuitive software for designing experiments, and the benchtop instrument itself. This high-throughput capability accelerates the design-build-test cycle, enabling researchers to more rapidly develop microbes for producing novel enzymes, therapeutic proteins, or sustainable chemicals. A significant milestone for the company was raising over $150 million in a Series D financing round, which has supported the commercial expansion of the Onyx platform. The company maintains operations in Pleasanton and Burlingame, California, serving a global customer base.

Source: Dealroom company data

Inscripta in the Pleasanton ecosystem

Live from Dealroom

The Inscripta office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

Series B and later11 investors entered at this stage

Employees mapped 20 incl. 2 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 10 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Inscripta on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.